Literature DB >> 26711751

Mutations That Enhance the Ciprofloxacin Resistance of Escherichia coli with qnrA1.

Laura Vinué1, Marian A Corcoran2, David C Hooper3, George A Jacoby4.   

Abstract

Plasmid-mediated qnr genes provide only a modest decrease in quinolone susceptibility but facilitate the selection of higher-level resistance. In Escherichia coli strain J53 without qnr, ciprofloxacin resistance often involves mutations in the GyrA subunit of DNA gyrase. Mutations in gyrA were absent, however, when 43 mutants with decreased ciprofloxacin susceptibility were selected from J53(pMG252) with qnrA1. Instead, in 13 mutants, individual and whole-genome sequencing identified mutations in marR and soxR associated with increased expression of marA and soxS and, through them, increased expression of the AcrAB pump, which effluxes quinolones. Nine mutants had increased expression of the MdtE efflux pump, and six demonstrated increased expression of the ydhE pump gene. Many efflux mutants also had increased resistance to novobiocin, another pump substrate, but other mutants were novobiocin hypersusceptible. Mutations in rfaD and rfaE in the pathway for inner core lipopolysaccharide (LPS) biosynthesis were identified in five such strains. Many of the pump and LPS mutants had decreased expression of OmpF, the major porin channel for ciprofloxacin entry. Three mutants had increased expression of qnrA that persisted when pMG252 from these strains was outcrossed. gyrA mutations were also rare when mutants with decreased ciprofloxacin susceptibility were selected from E. coli J53 with aac(6')-Ib-cr or qepA. We suggest that multiple genes conferring low-level resistance contribute to enhanced ciprofloxacin resistance selected from an E. coli strain carrying qnrA1, aac(6')-Ib-cr, or qepA because these determinants decrease the effective ciprofloxacin concentration and allow more common but lower-resistance mutations than those in gyrA to predominate.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26711751      PMCID: PMC4776012          DOI: 10.1128/AAC.02167-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  53 in total

1.  Interaction of plasmid and host quinolone resistance.

Authors:  Luis Martínez-Martínez; Alvaro Pascual; Isabel García; John Tran; George A Jacoby
Journal:  J Antimicrob Chemother       Date:  2003-02-25       Impact factor: 5.790

2.  MicC, a second small-RNA regulator of Omp protein expression in Escherichia coli.

Authors:  Shuo Chen; Aixia Zhang; Lawrence B Blyn; Gisela Storz
Journal:  J Bacteriol       Date:  2004-10       Impact factor: 3.490

3.  Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase.

Authors:  Ari Robicsek; Jacob Strahilevitz; George A Jacoby; Mark Macielag; Darren Abbanat; Chi Hye Park; Karen Bush; David C Hooper
Journal:  Nat Med       Date:  2005-12-20       Impact factor: 53.440

4.  Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).

Authors:  Jürgen A Bohnert; Sabine Schuster; Eva Fähnrich; Rainer Trittler; Winfried V Kern
Journal:  J Antimicrob Chemother       Date:  2006-10-24       Impact factor: 5.790

5.  R factors from Providence.

Authors:  R W Hedges
Journal:  J Gen Microbiol       Date:  1974-03

6.  Resistance in Escherichia coli: variable contribution of efflux pumps with respect to different fluoroquinolones.

Authors:  A Huguet; J Pensec; C Soumet
Journal:  J Appl Microbiol       Date:  2013-02-18       Impact factor: 3.772

7.  The Escherichia coli CpxA-CpxR envelope stress response system regulates expression of the porins ompF and ompC.

Authors:  Eric Batchelor; Don Walthers; Linda J Kenney; Mark Goulian
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

8.  Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli.

Authors:  G A Jacoby; P Han
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

9.  Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.

Authors:  K Hirai; H Aoyama; S Suzue; T Irikura; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

10.  Anaerobic expression of the gadE-mdtEF multidrug efflux operon is primarily regulated by the two-component system ArcBA through antagonizing the H-NS mediated repression.

Authors:  Ziqing Deng; Yue Shan; Qing Pan; Xiang Gao; Aixin Yan
Journal:  Front Microbiol       Date:  2013-07-11       Impact factor: 5.640

View more
  19 in total

1.  Resistance and Virulence Mechanisms of Escherichia coli Selected by Enrofloxacin in Chicken.

Authors:  Jun Li; Haihong Hao; Menghong Dai; Heying Zhang; Jianan Ning; Guyue Cheng; Muhammad Abu Bakr Shabbir; Abdul Sajid; Zonghui Yuan
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

2.  Multiple Copies of qnrA1 on an IncA/C2 Plasmid Explain Enhanced Quinolone Resistance in an Escherichia coli Mutant.

Authors:  Laura Vinué; Mohamad R A Sater; Ian Herriott; Miriam H Huntley; George A Jacoby; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

3.  Chromosomal mutations that accompany qnr in clinical isolates of Escherichia coli.

Authors:  Laura Vinué; David C Hooper; George A Jacoby
Journal:  Int J Antimicrob Agents       Date:  2018-01-31       Impact factor: 5.283

Review 4.  Plasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries.

Authors:  B Yanat; J-M Rodríguez-Martínez; A Touati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-26       Impact factor: 3.267

Review 5.  Transferable Mechanisms of Quinolone Resistance from 1998 Onward.

Authors:  Joaquim Ruiz
Journal:  Clin Microbiol Rev       Date:  2019-08-14       Impact factor: 26.132

6.  Limited Multidrug Resistance Efflux Pump Overexpression among Multidrug-Resistant Escherichia coli Strains of ST131.

Authors:  Johannes Camp; Sabine Schuster; Martina Vavra; Tobias Schweigger; John W A Rossen; Sandra Reuter; Winfried V Kern
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

Review 7.  Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance.

Authors:  David C Hooper; George A Jacoby
Journal:  Cold Spring Harb Perspect Med       Date:  2016-09-01       Impact factor: 6.915

8.  Characterization of Ciprofloxacin-Resistant and Ciprofloxacin-Susceptible Uropathogenic Escherichia coli Obtained from Patients with Gynecological Cancer.

Authors:  Muniqui S Capett; Patricia Vollú-Silva; Vanessa A Melchiades; Luciana C Bokehi; Fernanda M Araújo; Ianick Souto Martins; Felipe P G Neves; Alice G M Gonzalez; Eric Oswald; Geraldo R de Paula; Lenise A Teixeira
Journal:  Curr Microbiol       Date:  2016-07-26       Impact factor: 2.188

9.  Shared and Unique Evolutionary Trajectories to Ciprofloxacin Resistance in Gram-Negative Bacterial Pathogens.

Authors:  Jaime E Zlamal; Semen A Leyn; Mallika Iyer; Marinela L Elane; Nicholas A Wong; James W Wamsley; Maarten Vercruysse; Fernando Garcia-Alcalde; Andrei L Osterman
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

10.  Increased expression of Qnr is sufficient to confer clinical resistance to ciprofloxacin in Escherichia coli.

Authors:  Linnéa Garoff; Kavita Yadav; Diarmaid Hughes
Journal:  J Antimicrob Chemother       Date:  2018-02-01       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.